MediBeacon(R) Transdermal GFR System Receives FDA Approval to Assess Kidney Function
(NYSE:VATE), Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function The transdermal GFR (tGFR) methodology has been designed to be effective across the adult population without input of age, weight, sex, gender, race, or ethnicity More than 800 million people […]